Fr. 71.00

Impact of Patent Evergreening on Access to Medicine - A Juxtaposition from Consortium to Distribution

English, German · Paperback / Softback

Shipping usually within 2 to 3 weeks (title will be printed to order)

Description

Read more

Impact of Patent Evergreenig on Access to Medicine, as the title suggests is a reference book which deals with one of the prominent issues which hinder access to medicine i.e. Evergreening of Patents. Patents on the pharmaceutical product or process may be used to block generic completion by evergreening. This means getting patent on the product which is not novel but a simple change of existing known product. This blocks the access to affordable drugs posing a great threat to Public Health. In the developing world, where few people can afford original patented medicines, evergreening of patents poses a huge threat. This book is for students and scholars who want to understand this issue in depth and want to come up with probable solutions.

About the author










Sajid Sheikh presently teaches at Maharashtra National Law University Mumbai. He is pursuing his Ph.D. from NALSAR University of Law, Hyderabad. He obtained his LL.M. (Hons.) from National Law University, Jodhpur. Apart from this, he is the founder of Lawlex Organization, an NGO which is working in the field of Legal Education in India.

Product details

Authors Sajid Sheikh
Publisher LAP Lambert Academic Publishing
 
Languages English, German
Product format Paperback / Softback
Released 01.01.2016
 
EAN 9783659611711
ISBN 978-3-659-61171-1
No. of pages 104
Dimensions 150 mm x 220 mm x 6 mm
Weight 155 g
Subject Guides > Law, job, finance > Other law

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.